Savara is transitioning from a single-asset biotech to a rare disease commercial infrastructure. Click here to read more on ...
Microplastics (MP) are the subject of intensive medical research, but little is yet known about their effects on the immune ...
Despite recent advances in immunotherapy and targeted therapy, most patients with non-small-cell lung cancer (NSCLC) continue to have disease progression and develop resistance to current treatments.
Checking the fine particulate matter levels along with the weather every morning has become a daily routine. Research ...
Announcing a new article publication in BIO Integration. Pulmonary fibrosis (PF) is a progressive and irreversible ...
A team at Texas A&M University has shown that tiny biological particles, sprayed into the noses of aged mice, can quiet the ...